Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals

被引:7
作者
Achour, A
Bex, F
Hermans, P
Burny, A
Zagury, D
机构
[1] FREE UNIV BRUSSELS,B-1640 RHODE ST GENESE,BELGIUM
[2] HOP UNIV ST PIERRE,DEPT INFECT DIS,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1128/JVI.70.10.6741-6750.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytotoxic T lymphocytes (CTL) may be important to prevent cell-to-cell transmission of human immunodeficiency virus type 1 (HIV-1), the agent responsible for AIDS. In this study, we investigated the epitope specificity of CTLs induced in individuals immunized against the virus envelope glycoprotein gp160. The determinant of HIV-1 gp160 for the stimulation of CTL is located in a region df high sequence variability among HIV-1 isolates, the so-called V3 loop P18, Using a panel of P18 peptides, we compared the CTL specificities of cells from two individuals immunized with vaccinia virus recombinants expressing the envelope glycoproteins from two different strains of HIV-1, IIIB and SIMI. For this purpose, CTLs specific for the IIIB P18 peptide (RIQRGPGRAFVTIGK) were compared,vith CTLs for the site from the SIMI isolate (TLHMG PKRAFYATGD). The results indicate that in contrast to CD8(+) CTLs induced by the glycoprotein from strain IIIB, CD8(+) CTLs induced by strain SIMI strongly cross-reacted with targets presenting P18 peptides as well as envelope proteins from the divergent MN and RF isolates but failed to cross-react with targets that presented the IIIB peptide, These data have implications for the design of an HIV vaccine.
引用
收藏
页码:6741 / 6750
页数:10
相关论文
共 50 条
[1]   ENVELOPE PROTEIN AND P18(IIIB) PEPTIDE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES FROM HUMANS IMMUNIZED WITH HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE [J].
ACHOUR, A ;
PICARD, O ;
MBIKA, JP ;
WILLER, A ;
SNART, R ;
BIZZINI, B ;
CARELLI, C ;
BURNY, A ;
ZAGURY, D .
VACCINE, 1993, 11 (07) :699-701
[2]   HGP-30, A SYNTHETIC ANALOG OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17, IS A TARGET FOR CYTOTOXIC LYMPHOCYTES IN HIV-INFECTED INDIVIDUALS [J].
ACHOUR, A ;
PICARD, O ;
ZAGURY, D ;
SARIN, PS ;
GALLO, RC ;
NAYLOR, PH ;
GOLDSTEIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7045-7049
[3]   CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR HIV-1 GP160 ANTIGEN AND SYNTHETIC P18III(B) PEPTIDE IN AN HLA-A11-IMMUNIZED INDIVIDUAL [J].
ACHOUR, A ;
LEMHAMMEDI, S ;
PICARD, O ;
MBIKA, JP ;
ZAGURY, JF ;
MOUKRIM, Z ;
WILLER, A ;
BEIX, F ;
BURNY, A ;
ZAGURY, D .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (01) :19-25
[4]  
Achour Ammar, 1995, Immunology and Infectious Diseases (Oxford), V5, P270
[5]   CORRELATION BETWEEN CD8 DEPENDENCY AND DETERMINANT DENSITY USING PEPTIDE-INDUCED, LD-RESTRICTED CYTOTOXIC LYMPHOCYTES-T [J].
ALEXANDER, MA ;
DAMICO, CA ;
WIETIES, KM ;
HANSEN, TH ;
CONNOLLY, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :849-858
[6]  
ALEXANDERMILLER MA, 1995, AIDS RES HUM RETROV, V11, pS133
[7]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[8]  
BEX F, 1994, BLOOD, V10, P3317
[9]   GAG-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED INDIVIDUALS - GAG EPITOPES ARE CLUSTERED IN 3 REGIONS OF THE P24GAG PROTEIN [J].
BUSEYNE, F ;
MCCHESNEY, M ;
PORROT, F ;
KOVARIK, S ;
GUY, B ;
RIVIERE, Y .
JOURNAL OF VIROLOGY, 1993, 67 (02) :694-702
[10]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208